Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2 - PubMed (original) (raw)
. 1993 Jul 5;268(19):14033-9.
Affiliations
- PMID: 8314771
Free article
Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2
A Y Strongin et al. J Biol Chem. 1993.
Free article
Abstract
Human 72-kDa type IV collagenase (72T4Cl) is secreted as a proenzyme that can form a specific stoichiometric complex with the tissue inhibitor of metalloproteases TIMP-2 via interaction with the carboxyl-terminal domain of the enzyme. Both complexed and free enzymes can be activated by treatment with organomercurials. The mechanism of the 72T4Cl activation under physiological conditions is not known. Here we describe a "plasma membrane-dependent" activation of inhibitor-free 72T4Cl and identify the first conversion intermediate as a 64-kDa species resulting from cleavage of the Asn37-Leu peptide bond in the presence of plasma membranes from 12-O-tetradecanoylphorbol-13-acetate-induced HT1080 cells. This reaction is specific for 72T4Cl in that a closely related proenzyme (92-kDa type IV collagenase) is resistant to activation under the same conditions. Formation of the 72T4Cl.TIMP-2 complex inhibits activation at the level of the initial Asn37-Leu cleavage. Addition of TIMP-1 has no effect on this reaction, but blocks the autocatalytic conversion of the Leu38 intermediate into a 62-kDa active enzyme with an amino-terminal Tyr81. Membrane-dependent activation of 72T4Cl is competitively inhibited in the presence of a 26-kDa peptide derived from the carboxyl-terminal domain of the enzyme. The results suggest that interaction of the carboxyl-terminal domain of the enzyme with a membrane-associated component(s) causes initiation of enzyme activation through an autoproteolytic mechanism.
Similar articles
- Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.
Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Strongin AY, et al. J Biol Chem. 1995 Mar 10;270(10):5331-8. doi: 10.1074/jbc.270.10.5331. J Biol Chem. 1995. PMID: 7890645 - Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T. Okada Y, et al. J Biol Chem. 1992 Oct 25;267(30):21712-9. J Biol Chem. 1992. PMID: 1400481 - Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Goldberg GI, Collier IE, Eisen AZ, Grant GA, Marmer BL, Wilhelm SM. Goldberg GI, et al. Matrix Suppl. 1992;1:25-30. Matrix Suppl. 1992. PMID: 1336109 - Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2.
DeClerck YA, Yean TD, Lu HS, Ting J, Langley KE. DeClerck YA, et al. J Biol Chem. 1991 Feb 25;266(6):3893-9. J Biol Chem. 1991. PMID: 1847392
Cited by
- Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism.
Hernandez-Anzaldo S, Brglez V, Hemmeryckx B, Leung D, Filep JG, Vance JE, Vance DE, Kassiri Z, Lijnen RH, Lambeau G, Fernandez-Patron C. Hernandez-Anzaldo S, et al. J Am Heart Assoc. 2016 Sep 30;5(10):e004228. doi: 10.1161/JAHA.116.004228. J Am Heart Assoc. 2016. PMID: 27694328 Free PMC article. - Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K, Lohi J, Valtanen H, Keski-Oja J. Lehti K, et al. Biochem J. 1998 Sep 1;334 ( Pt 2)(Pt 2):345-53. doi: 10.1042/bj3340345. Biochem J. 1998. PMID: 9716492 Free PMC article. - Gelatinase A activity directly modulates melanoma cell adhesion and spreading.
Ray JM, Stetler-Stevenson WG. Ray JM, et al. EMBO J. 1995 Mar 1;14(5):908-17. doi: 10.1002/j.1460-2075.1995.tb07072.x. EMBO J. 1995. PMID: 7534227 Free PMC article. - Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.
Toschi E, Barillari G, Sgadari C, Bacigalupo I, Cereseto A, Carlei D, Palladino C, Zietz C, Leone P, Stürzl M, Buttò S, Cafaro A, Monini P, Ensoli B. Toschi E, et al. Mol Biol Cell. 2001 Oct;12(10):2934-46. doi: 10.1091/mbc.12.10.2934. Mol Biol Cell. 2001. PMID: 11598182 Free PMC article. - Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin.
Marchenko GN, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI, Strongin AY. Marchenko GN, et al. Biochem J. 2001 Jun 15;356(Pt 3):705-18. doi: 10.1042/0264-6021:3560705. Biochem J. 2001. PMID: 11389678 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous